Oddo BHF - Verallia SAS (VRLA) Verallia : Une inflexion confirmée pour les volumes – Objectifs annuels inchangés

Report

Oddo BHF

Jean-François Granjon

Verallia : Une inflexion confirmée pour les volumes – Objectifs annuels inchangés

>Publication des résultats T3 / 9 mois en ligne avec nos attentes - Verallia publie un CA T3 de 870.6 M€ (897 M€ estimé, 875.4 M€ pour le css) vs 931.8 M€ en repli de 6.6% et -4.7% en organique principalement en raison de baisses de prix. Aussi, pour les 9 mois, le CA ressort à 2635.2 M€ (2661.6 M€ estimé, 2640.0 M€ pour le css) vs 3074.5 M€ en repli de 14.3% et -8.7% en organique traduisant un ralentissement de la baisse d’activité. L’EBITDA T3 ressort à 210 M€ (215 ...

23/10/2024 1 FR

Underlying

Verallia SAS

Verallia SAS Formerly known as Verallia SASU. Verallia SASU is a France-based company, which operates as a producer of glass packaging solutions. The Company manufactures a number of jars and bottles for various markets, including the still and sparkling wine, spirits, food, as well as the beer and nonalcoholic sectors. Apart from France, the Company also operates in many countries in Western Europe, Eastern Europe and South America, among others.

See profile

FR0013447729 Euronext Paris France

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Jean-François Granjon

Other Reports on these Companies

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 10/23/2024

28 October could mark a crucial step forward in the resolution of the asbestos litigation. The hearing set on this date at the Delaware court could lead to the launch of the plaintiffs’ vote on the reorganisation plan (agreement if 75% of plaintiffs vote in favour of the plan). We think that this vote is highly likely to materialise, notably with the integration of J&J into the plan (hearing of 8 October). The intrinsic valuation of the group’s assets (TQC, the Beauvoir/Saint-Austell ...

1h / 12m 1h / 12m 1 EN

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 23/10/2024

Le 28 octobre prochain pourrait marquer une avancée cruciale dans la résolution des litiges amiante. L’audience prévue pour cette date dans l’agenda du tribunal du Delaware pourrait conduire au lancement du vote des plaignants sur le plan de réorganisation (accord si 75% des plaignants votent le plan). Nous pensons que ce vote a de grandes chances d’aboutir avec l’intégration de J&J dans le plan (décision du 8 octobre dernier). La valorisation intrinsèque des actifs du groupe reviendr...

1h / 30m 1h / 30m 1 FR

Oddo BHF

Credit Morning 10/23/2024

ELO: the investigation into suspicions of tax fraud laundering and breach of trust against companies in the Mulliez Group and their directors has been dismissed.Verallia: volumes stabilize slightly in Q3 and bond issue possible in the near future>...

2h / 1m 2h / 1m 1 EN

Eurofins : Plus de clarifications sur la Biopharma – une réaction du marché un peu exagérée – OC ajusté à 55 € vs 58 €

>Principal point de la confcall : décryptage de la baisse de la division Biopharma - Le groupe a tenu sa conf call hier à 15h, et le titre a clôturé en baisse de 11.2%. Bien que la sanction boursière nous semble un peu sévère, elle peut être expliquée par l’accumulation de plusieurs points négatif, malgré une performance globalement satisfaisante. Voici les principaux points que nous retenons :Précisions sur la division Biopharma : la croissance en Amériques du...

31m 31m 1 FR

Sinan Doganli

Sinan Doganli

ODDO BHF Small & MIDCAP MORNING NEWS - 10/23/2024

1h / 12m 1h / 12m 1 EN

Jerôme Bodin

Jerôme Bodin

Vivendi : Q3 sales a shade below expectations, no new information on the demerger

>Outperform rating with the outlook of the demerger - Vivendi published its Q3 2024 revenues yesterday evening. The group did not hold a conference call. This publication is based on the scope of future listed entities. Q3 revenues slightly undershot our expectations, with a sharper fall in revenues for Canal+. However, there was nothing dramatic about this performance, which in our view does not represent a break in the trend. The group did not hold a conference call...

1h / 13m 1h / 13m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Verallia : Une inflexion confirmée pour les volumes – Objectifs annuels inchangés

ODDO BHF Small & MIDCAP MORNING NEWS - 10/23/2024

ODDO BHF Small & MIDCAP MORNING NEWS - 23/10/2024

Credit Morning 10/23/2024

Eurofins : Plus de clarifications sur la Biopharma – une réaction du marché un peu exagérée – OC ajusté à 55 € vs 58 €

ODDO BHF Small & MIDCAP MORNING NEWS - 10/23/2024

Vivendi : Q3 sales a shade below expectations, no new information on the demerger

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe